Northwest Biotherapeutics proposes direct public offering

Northwest Biotherapeutics Inc. (NASDAQ:NWBO), Bethesda, Md. Business: Cancer Date announced: 4/18/13 Type: Direct public offering To be raised: $10 million Shares: TBD Price: $3.90 Placement agent: H....